SeaStar Medical Holding Corporation (ICU) is a Healthcare · Biotechnology company listed on NASDAQ. Price $3.62 (+3.51%), Market cap $0.02B, 52-week low–high $0.23 ~ $4.87.
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hep
Financial statements, price targets, institutional (13F) holdings and related news for SeaStar Medical Holding Corporation are updated in real time on BlackAll Trade.
SeaStar Medical Holding Corporation trades at $3.62 (+3.51%). Real-time quotes and charts are available on BlackAll Trade.
SeaStar Medical Holding Corporation has a market cap of about $0.02B.
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States